Streetbeat News

Stock Prices

NLSP

NLSPW

NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) announced promising results from its preclinical study KO-874 on mazindol's neuroprotective effects in a narcoleptic-like rat model. The findings were presented at the American Society of Clinical Psychopharmacology (ASCP) in Miami.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:07 pm

AGAE

DKNG

GME

KIRK

SVMH

TKLF

The article highlights the pre-market movements of several consumer discretionary stocks on Tuesday. Notable gainers include Yoshitsu Co (TKLF), GameStop (GME), and Kirkland's (KIRK), while significant losers include SRIVARU Holding (SVMH), DraftKings (DKNG), and Allied Gaming (AGAE).

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 12:07 pm

AGIO

AKAN

CALT

CORT

EFTR

INSM

LUCY

ONCO

ONMD

POAI

RNAZ

STSS

12 health care stocks showed significant movements in Tuesday's pre-market session. Sharps Technology, Insmed, and Calliditas Therapeutics were among the top gainers, while Innovative Eyewear and OneMedNet were notable losers.

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 12:07 pm

LGCL

LICN

OPTT

PEGY

SGLY

SMR

The article highlights the pre-market movements of 12 industrial stocks on Tuesday. Notable gainers include Pineapple Energy (PEGY), Ocean Power Techs (OPTT), and NuScale Power (SMR). Significant losers include Lichen China (LICN), Lucas GC (LGCL), and Singularity Future Tech (SGLY).

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 12:07 pm

ASTI

LAW

MINM

OBLG

TUYA

The article highlights the pre-market movements of various Information Technology stocks on Tuesday. Notable gainers include Oblong (NASDAQ:OBLG), CS Disco (NYSE:LAW), and Tuya (NYSE:TUYA), while significant losers include Ascent Solar Technologies (NASDAQ:ASTI) and Minim (NASDAQ:MINM).

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 12:07 pm

MYNZ

Mainz Biomed (NASDAQ: MYNZ) presented new pooled colorectal cancer screening data at the ASCO 2024 Annual Meeting, showing 92.3% sensitivity for colorectal cancer and 82.3% for advanced precancerous lesions. The data includes 690 subjects from the ColoFuture and eAArly DETECT studies.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:07 pm

ENSC

Ensysce Biosciences (NASDAQ:ENSC) has regained compliance with Nasdaq's equity requirement, ensuring its continued listing on the Nasdaq Capital Market tier.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:06 pm

AUVI

CALT

GME

STSS

TKLF

GameStop shares surged 17.6% in pre-market trading after completing its at-the-market equity offering program, raising $933.4 million. Other notable pre-market movers include Sharps Technology, Calliditas Therapeutics, and Yoshitsu Co., among others.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 12:04 pm

ABBV

AbbVie (NYSE:ABBV) will present new data from its innovative antibody-drug conjugate (ADC) platform at the ASCO 2024 Annual Meeting. The data includes results from Phase 1 and Phase 2 studies on various ADCs targeting different cancer types.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:03 pm

NNOX

Nano X Imaging reported its Q1 2024 results with an adjusted EPS of $(0.14), beating the estimate of $(0.26). However, sales were $2.553M, missing the $4.415M estimate.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:03 pm